Giulio Metro

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

Biagio Ricciuti, Carlo Genova, Andrea De Giglio et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 357 citations · Full text

Medicine, Immunology, Multi-institutional Analysis +8

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

Alessio Cortellini, Rita Chiari, Biagio Ricciuti et al. · Clinical Lung Cancer · 2019 · 174 citations

Cancer Immunosurveillance, Anti-pd1 Immunotherapy, Immunodeficiencies +9

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Giulio Metro, Jennifer Foglietta, Michelangelo Russillo et al. · Annals of Oncology · 2010 · 167 citations

Neuro-oncology, Breast Oncology, Brain Metastases +9

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

Alessio Cortellini, Massimo Di Maïo, Olga Nigro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 132 citations · Full text

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

Alessandra Fabi, Alessandra Felici, Giulio Metro et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 118 citations · Full text